Impact of a Brief Motivational Interview on Drinking Behaviors of At Risk Drinkers Screened in the Emergency Room

NCT ID: NCT00183183

Last Updated: 2010-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1137 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-04-30

Study Completion Date

2005-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Alcohol abuse is associated with injury, chronic illness, absenteeism from work, and social costs to families and communities. The goal of this project is to translate motivational interventions successful in the primary care setting to the Emergency Department (ED) environment by implementing screening, brief intervention and referral to treatment (SBIRT) in order to reduce at-risk drinking among ED patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To evaluate the effectiveness of SBIRT in the emergency room setting, ED patients meeting NIAAA criteria for high risk drinking were recruited from 14 sites nationwide (control group-Spring, 2004; intervention group-Summer, 2004). 26% of screened ED patients met inclusion criteria. All enrollees received a list of local referral resources. Intervention group patients also participated in a 15 minute negotiated interview and ED staff referred them directly for treatment if indicated. Enrollees completed 3-month follow-up surveys with a telephone Interactive Voice Response (IVR) system. A total of 1137 patients were enrolled across 14 sites (561 intervention, 576 control), with 62% male, 37% Black, and 38% White, and a mean age of 37. At baseline intervention-i and control-c groups were similar in demographic characteristics and number of drinks on a typical day (mean-i 5.00, mean-c 5.12) and maximum drinks on a given day in the past month (mean-i 7.51, mean-c 7.33). The 3 month follow-up rate was 62% (n=687); the 6 month follow-up rate was 52% (n=567). The 12 month follow up is currently underway.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Screening and Brief Intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18+
* Communication in English or Spanish
* Met NIAAA criteria for "at-risk drinking":

* for Men: 15 or more drinks/week, or 5 or more drinks on a single occasion
* for Women: 8 or more drinks/week, or 4 or more drinks on a single occasion
* Age 65 or over: 8 or more drinks/week or more than 1 drink per day

Exclusion Criteria

* Requests detox or already in alcohol treatment program
* Abnormal mental status
* Too ill to give consent
* Unable to provide consent for other reasons
* Suicidal
* Employee or student of site institution (where required)
* Prisoner
* Inability to follow up
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

Sponsor Role collaborator

UConn Health

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Edward Bernstein, MD

Role: PRINCIPAL_INVESTIGATOR

Boston University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charles R. Drew University of Medicine and Science/Matrin Luther King Hospital

Los Angeles, California, United States

Site Status

University of Southern California Keck School of Medicine / Los Angeles County+University of Southern California Medical Center

Los Angeles, California, United States

Site Status

University of California San Diego Medical Center - Hillcrest

San Diego, California, United States

Site Status

University of Denver/Denver Health Medical Center

Denver, Colorado, United States

Site Status

University of Connecticut Health Center

Farmington, Connecticut, United States

Site Status

Section of Emergency Medicine/Yale University School of Medicine

New Haven, Connecticut, United States

Site Status

Howard University/College of Medicine/Department of Pharmacology and Emergency Medicine

Washington D.C., District of Columbia, United States

Site Status

Department of Emergency Medicine Emory University School of Medicine / Emergency Care Center of the Grady Memorial Hospital

Atlanta, Georgia, United States

Site Status

Boston University Medical Center

Boston, Massachusetts, United States

Site Status

Tufts-New England Medical Center Hospital/Tufts University

Boston, Massachusetts, United States

Site Status

University of Michigan Hospital and Health System / Department of Emergency Medicine

Ann Arbor, Michigan, United States

Site Status

Cooper Health/Department of Emergency Medicine at UMNDJ-RWJMS

Camden, New Jersey, United States

Site Status

The University of New Mexico Hospital/Health Sciences Center

Albuquerque, New Mexico, United States

Site Status

Rhode Island Hospital / Brown University / Department of EM and Injury Prevention Center

Providence, Rhode Island, United States

Site Status

University of Virginia Health System, University Hospital

Charlottesville, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R21AA015123

Identifier Type: NIH

Identifier Source: secondary_id

View Link

NIH 5R21AA15123-02

Identifier Type: -

Identifier Source: secondary_id

NIAAAASE15123

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multi-Component Breath Alcohol Intervention
NCT06124898 ACTIVE_NOT_RECRUITING NA